EUVIMEDAtklāt EUVIMED
Open access · CC BY 4.0

Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid

Clara Domingo-Sabugo iD, Saffron Ag Willis-Owen, Amit Mandal, Anca Nastase, Sarah Dwyer, Cecilia Brambilla, José Héctor Gálvez, Qinwei Zhuang, Sanjay Popat, Robert Eveleigh, Markus Munter, Eric Lim and 4 more

The Journal of Pathology · 2024

DOI: 10.1002/path.6352 ↗

At a glance

Journal article in The Journal of Pathology, 2024. Written by Clara Domingo-Sabugo and 15 co-authors. Institution: National Heart and Lung Institute, Imperial College London, London, UK. Major MEDLINE topics: Lung Neoplasms, Carcinoid Tumor, Mutation, Biomarkers, Tumor. Cited 8 times so far (Crossref); 61 references. The full text is freely available (open access, CC BY 4.0). Funded by: UK Department of Health, The Asmarley Trust, Wellcome.

AbstraktsSubjectsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

Lung carcinoids (L‐CDs) are rare, poorly characterised neuroendocrine tumours (NETs). L‐CDs are more common in women and are not the consequence of cigarette smoking. They are classified histologically as typical carcinoids (TCs) or atypical carcinoids (ACs). ACs confer a worse survival. Histological classification is imperfect, and there is increasing interest in molecular markers. We therefore investigated global transcriptomic and epigenomic profiles of 15 L‐CDs resected with curative intent at Royal Brompton Hospital. We identified underlying mutations and structural abnormalities through whole‐exome sequencing (WES) and single nucleotide polymorphism (SNP) genotyping. Transcriptomic clustering algorithms identified two distinct L‐CD subtypes. These showed similarities either to pancreatic or neuroendocrine tumours at other sites and so were named respectively L‐CD‐PanC and L‐CD‐NeU. L‐CD‐PanC tumours featured upregulation of pancreatic and metabolic pathway genes matched by promoter hypomethylation of genes for beta cells and insulin secretion ( p < 1 × 10 −6 ). These tumours were centrally located and showed mutational signatures of activation‐induced deaminase/apolipoprotein B editing complex activity, together with genome‐wide DNA methylation loss enriched in repetitive elements ( p = 2.2 × 10 −16 ). By contrast, the L‐CD‐NeU group exhibited upregulation of neuronal markers (adjusted p < 0.01) and was characterised by focal spindle cell morphology ( p = 0.04), peripheral location ( p = 0.01), high mutational load ( p = 2.17 × 10 −4 ), recurrent copy number alterations, and enrichment for ACs. Mutations affected chromatin remodelling and SWI/SNF complex pathways. L‐CD‐NeU tumours carried a mutational signature attributable to aflatoxin and aristolochic acid ( p = 0.05), suggesting a possible environmental exposure in their pathogenesis. Immunologically, myeloid and T‐cell markers were enriched in L‐CD‐PanC and B‐cell markers in L‐CD‐NeU tumours. The substantial epigenetic and non‐coding differences between L‐CD‐PanC and L‐CD‐NeU open new possibilities for biomarker selection and targeted treatment of L‐CD. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Lung NeoplasmsCarcinoid TumorMutationBiomarkers, TumorHumansFemaleMaleMiddle AgedAgedPancreatic NeoplasmsAdultDNA MethylationExome SequencingPolymorphism, Single NucleotideTranscriptomeGenomicsGene Expression ProfilingGene Expression Regulation, Neoplastic

Author keywords

DNA methylationbiomarker identificationclustersfunctional enrichmentlung carcinoidmolecular subtypesmultiomicsmutational signaturesneuroendocrine tumours

Substances

Biomarkers, Tumor

Authors and institutions

  • National Heart and Lung Institute, Imperial College London, London, UK.
  • Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University, Montréal, QC, Canada.
  • Royal Marsden Hospital NHS Foundation Trust, London and Surrey, UK.
  • The Institute of Cancer Research, London, UK.
  • Department of Thoracic Surgery, Royal Brompton Hospital, London, UK.

ORCID profiles: Clara Domingo-Sabugo, William Oc Cookson

Funding

  • UK Department of Health
  • The Asmarley Trust
  • Wellcome
  • Wellcome Trust

Cite

APA

Domingo-Sabugo, C., Willis-Owen, S. A., Mandal, A., Nastase, A., Dwyer, S., Brambilla, C., Gálvez, J. H., Zhuang, Q., Popat, S., Eveleigh, R., Munter, M., Lim, E., Nicholson, A. G., Lathrop, G. M., Cookson, W. O., & Moffatt, M. F. (2024). Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid. The Journal of Pathology. https://doi.org/10.1002/path.6352

Vancouver

Domingo-Sabugo C, Willis-Owen SA, Mandal A, Nastase A, Dwyer S, Brambilla C, et al. Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid. The Journal of Pathology. 2024. doi:10.1002/path.6352

BibTeX
@article{DomingoSabugo2024,
  author = {Domingo-Sabugo, Clara and Willis-Owen, Saffron Ag and Mandal, Amit and Nastase, Anca and Dwyer, Sarah and Brambilla, Cecilia and Gálvez, José Héctor and Zhuang, Qinwei and Popat, Sanjay and Eveleigh, Robert and Munter, Markus and Lim, Eric and Nicholson, Andrew G and Lathrop, G Mark and Cookson, William Oc and Moffatt, Miriam F},
  title = {Genomic analysis defines distinct pancreatic and neuronal subtypes of lung carcinoid},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6352}
}
Start for free →